An FMRI meta-analysis of interoception in eating disorders
Abstract
Eating Disorders (EDs) are associated with disturbed interoception - the sense of the internal condition of the body. Disturbances in interoception across senses have not yet been comprehensively examined in EDs. To do so, we employed an innovative Bayesian author-topic model approach to fMRI meta-analyses that pools together neural deficits across interoceptive senses and task types in participants with and recovered from EDs. Following PRISMA guidelines, our results combine activation patterns from 1,341 initially screened studies and data from 25 manuscripts that met study criteria that compare 463 patients with EDs (current or recovered) to 450 healthy control participants (HC). Altered brain activity was found within vision/sensory processing (precuneus), taste/self-referential processing (claustrum/posterior insula) and reward/set-shifting (global pallidus, medial frontal gyrus, anterior cingulate, precentral gyrus and parietal lobe) components in EDs compared to HC. Our results reveal separate components for bottom-up exteroceptive and interoceptive processing centering around the precuneus and claustrum/insula and also reward processing/set-shifting deficits. Thus, bottom-up sensory and reward processing are key deficits in EDs during ill and recovered states.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 463 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.